Search
Close this search box.

Get our email updates

Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.

Advertisement
Advertisement

Ithaca’s GrammaTech wins more than $8 million in research contracts

ITHACA — GrammaTech, Inc., an Ithaca–based software company specializing in software-assurance and cyber security, announced that it has recently won more than $8.25 million in research contracts from government agencies.

In the past four months, the company submitted eight proposals, six of which have been selected for funding, GrammaTech said in a news release. The remaining two proposals are still pending. The company didn’t specify the government agencies from which it received the contracts.

But over its 25-year history, GrammaTech has performed sponsored research for many branches of the U.S. government, including the Department of Defense, Department of Homeland Security, National Aeronautics and Space Administration, National Institute of Standards and Technology, and the National Science Foundation, the company says.

(Sponsored)

“These awards underscore the company’s continued success and the strength of our research team, which includes world-class experts in automated program analysis,” Tim Teitelbaum, GrammaTech’s CEO and professor emeritus in Cornell’s Computer Science Department, said in the release.

GrammaTech was originally a spin-off of Cornell University. It was co-founded by Cornell computer science professors Thomas Reps and Tim Teitelbaum, according to the company’s website. The staff of GrammaTech includes 16 Ph.D. experts in program analysis and an engineering team, all focused on creating analysis algorithms, the release said.

The company says its static analysis tools are used worldwide by Fortune 500 companies, educational institutions, startups, and government agencies. Its CodeSonar software, for example, is adopted by NASA to harden its Mars Rover software and by the FDA to inspect the software of a malfunctioning medical device, according to the release.

 

 

Contact The Business Journal at news@cnybj.com

Post
Share
Tweet
Print
Email

Get our email updates

Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.

Essential business news, thoughtful analysis and valuable insights for Central New York business leaders.

Copyright © 2023 Central New York Business Journal. All Rights Reserved.